Andreas Fahlström
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andreas Fahlström has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Parmenion P. Tsitsopoulos
Department of Medical Sciences, Section of Neurosurgery, Uppsala University, Uppsala, Sweden; Department of Neurosurgery, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
4 shared publicationsAmel Hessington
Department of Neuroscience, Neurosurgery, Uppsala University, Uppsala University Hospital, Uppsala
3 shared publications- Brun Ulfhake
Department of Laboratory Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden
3 shared publications Ebba Troberg
Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Neurosurgery, Lund, Sweden
3 shared publicationsHenrietta Nittby Redebrandt
Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Neurosurgery, Lund, Sweden
3 shared publications- Hugo Zeberg
Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany
3 shared publications
Latest Publications
- 23 January 2026
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- Vol. 104 (5) , 341-353
Preoperative Brain Atrophy as a Predictor of Motor Outcomes after Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease
Introduction: Brain atrophy is common in Parkinson’s disease (PD) and contributes to motor and cognitive decline. However, the predictive value of neuroimaging-based volumetric measures for motor outcomes following deep brain stimulation (DBS) remains unclear. Notably, subclinical dementia may play a key role in DBS response. This study examines whether preoperative volumetric assessment can predict motor outcomes after subthalamic nucleus (STN) DBS in PD. Methods: Preoperative T1-weighted 3D MP-RAGE magnetic resonance images scans were analyzed to measure subcortical, ventricular, and cortical volumes using Brainlab software. Motor outcomes were assessed by changes in the Movement Disorder Society – Unified Parkinson’s Disease Rating Scale part III (MDS-UPDRS-III) scores pre- and postoperatively in 39 participants. Stepwise logistic regression was performed to determine associations between brain volumes and DBS response. Results: Smaller substantia nigra compacta volume {0.81 (interquartile range [IQR]: 0.74–0.85) vs. 0.72 [IQR: 0.69–0.73]), larger ventricular system (26.1 [IQR: 21.4–30.05] vs. 34.1 [IQR: 28.6–40.87]), and lower atrophy ratio (41.76 [IQR: 37.59–50.71] vs. 29.63 [IQR: 25.9–36.55]) were significantly associated with reduced motor improvement following STN-DBS. The predictive model based on these values demonstrated excellent performance (area under the receiver operating characteristic curve = 0.95, 95% CI: 0.87–1; p < 0.01) in forecasting poorer DBS treatment outcomes as measured by the MDS-UPDRS-III scale. Additionally, lower thalamic volume and poorer executive function (assessed by the Frontal Assessment Battery) correlated positively with a lower atrophy ratio. Conclusion: Our findings highlight the impact of enlargement of ventricular system and brain atrophy, particularly of the substantia nigra, on motor outcomes after STN-DBS. The association between atrophy measures and executive dysfunction suggests that subclinical dementia may underlie poor DBS response. Brain atrophy could serve as an early marker of cognitive decline, influencing postoperative disease progression and treatment outcomes. Future studies should further explore the role of neurodegeneration in DBS response to optimize patient selection and electrode targeting.
- 23 January 2026
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- Vol. 104 (5) , 341-353
Preoperative Brain Atrophy as a Predictor of Motor Outcomes after Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease
Introduction: Brain atrophy is common in Parkinson’s disease (PD) and contributes to motor and cognitive decline. However, the predictive value of neuroimaging-based volumetric measures for motor outcomes following deep brain stimulation (DBS) remains unclear. Notably, subclinical dementia may play a key role in DBS response. This study examines whether preoperative volumetric assessment can predict motor outcomes after subthalamic nucleus (STN) DBS in PD. Methods: Preoperative T1-weighted 3D MP-RAGE magnetic resonance images scans were analyzed to measure subcortical, ventricular, and cortical volumes using Brainlab software. Motor outcomes were assessed by changes in the Movement Disorder Society – Unified Parkinson’s Disease Rating Scale part III (MDS-UPDRS-III) scores pre- and postoperatively in 39 participants. Stepwise logistic regression was performed to determine associations between brain volumes and DBS response. Results: Smaller substantia nigra compacta volume {0.81 (interquartile range [IQR]: 0.74–0.85) vs. 0.72 [IQR: 0.69–0.73]), larger ventricular system (26.1 [IQR: 21.4–30.05] vs. 34.1 [IQR: 28.6–40.87]), and lower atrophy ratio (41.76 [IQR: 37.59–50.71] vs. 29.63 [IQR: 25.9–36.55]) were significantly associated with reduced motor improvement following STN-DBS. The predictive model based on these values demonstrated excellent performance (area under the receiver operating characteristic curve = 0.95, 95% CI: 0.87–1; p < 0.01) in forecasting poorer DBS treatment outcomes as measured by the MDS-UPDRS-III scale. Additionally, lower thalamic volume and poorer executive function (assessed by the Frontal Assessment Battery) correlated positively with a lower atrophy ratio. Conclusion: Our findings highlight the impact of enlargement of ventricular system and brain atrophy, particularly of the substantia nigra, on motor outcomes after STN-DBS. The association between atrophy measures and executive dysfunction suggests that subclinical dementia may underlie poor DBS response. Brain atrophy could serve as an early marker of cognitive decline, influencing postoperative disease progression and treatment outcomes. Future studies should further explore the role of neurodegeneration in DBS response to optimize patient selection and electrode targeting.
- Open Access
- 5 April 2024
- Published by Elsevier in World Neurosurgery
- Vol. 186, e539-e551
Predictors of 30-Day Mortality for Surgically Treated Patients with Spontaneous Supratentorial Intracerebral Hemorrhage and Validation of the Surgical Swedish Intracerebral Hemorrhage Score: A Retrospective Single-Center Analysis of 136 Cases
- 5 April 2024
- Published by Elsevier in World Neurosurgery
- Vol. 186, e539-e551
Open AccessPredictors of 30-Day Mortality for Surgically Treated Patients with Spontaneous Supratentorial Intracerebral Hemorrhage and Validation of the Surgical Swedish Intracerebral Hemorrhage Score: A Retrospective Single-Center Analysis of 136 Cases
- Open Access
- 26 July 2023
- Published by Georg Thieme Verlag KG in Indian Journal of Neurosurgery
- Vol. 12 (02) , 104-115
H3 K27M-Altered Diffuse Midline Gliomas: A Review
Diffuse midline glioma H3 K27M-altered is a recently renamed high-grade glioma in the 2021 World Health Organization (WHO) Classification of Central Nervous System Tumors, previously being labelled diffuse midline glioma H3 K27M-mutant in the 2016 update and diffuse intrinsic pontine glioma prior to 2016. After identification of multiple alterations causing H3 K27 hypomethylation, the definition of this tumor subtype was changed. To further characterize this new entity in both the pediatric and adult population, we conducted a review of the current literature, investigating genetic, epidemiological, clinical, radiological, histopathological, treatment and prognostic characteristics, particularly highlighting the differences between adults and children. This tumor is more common in children, and has a poorer prognosis. Additionally, childhood H3 K27-altered gliomas are more common in the brainstem, but more common in the thalamus in adults. Sadly, limited treatment options exist for these tumors, with radiotherapy the only treatment shown to improve overall survival.
- 26 July 2023
- Published by Georg Thieme Verlag KG in Indian Journal of Neurosurgery
- Vol. 12 (02) , 104-115
Open AccessH3 K27M-Altered Diffuse Midline Gliomas: A Review
Diffuse midline glioma H3 K27M-altered is a recently renamed high-grade glioma in the 2021 World Health Organization (WHO) Classification of Central Nervous System Tumors, previously being labelled diffuse midline glioma H3 K27M-mutant in the 2016 update and diffuse intrinsic pontine glioma prior to 2016. After identification of multiple alterations causing H3 K27 hypomethylation, the definition of this tumor subtype was changed. To further characterize this new entity in both the pediatric and adult population, we conducted a review of the current literature, investigating genetic, epidemiological, clinical, radiological, histopathological, treatment and prognostic characteristics, particularly highlighting the differences between adults and children. This tumor is more common in children, and has a poorer prognosis. Additionally, childhood H3 K27-altered gliomas are more common in the brainstem, but more common in the thalamus in adults. Sadly, limited treatment options exist for these tumors, with radiotherapy the only treatment shown to improve overall survival.
- Open Access
- 1 May 2023
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 5 (Supplement) , i35-i48
Multiple meningiomas: Epidemiology, management, and outcomes
Meningiomas are the most common nonmalignant brain tumor in adults, with an increasing incidence of asymptomatic meningiomas diagnosed on more ubiquitous neuroimaging. A subset of meningioma patients bear 2 or more spatially separated synchronous or metachronous tumors termed “multiple meningiomas” (MM), reported to occur in only 1%–10% of patients, though recent data indicate higher incidence. MM constitute a distinct clinical entity, with unique etiologies including sporadic, familial and radiation-induced, and pose special management challenges. While the pathophysiology of MM is not established, theories include independent origin in disparate locations through unique genetic events, and the “monoclonal hypothesis” of a transformed neoplastic clone with subarachnoid seeding precipitating numerous distinct meningiomas. Patients with solitary meningiomas carry the risk of long-term neurological morbidity and mortality, as well as impaired health-related quality of life, despite being a generally benign and surgically curable tumor. For patients with MM, the situation is even less favorable. MM should be regarded as a chronic disease, and in many cases, the management goal is disease control, as cure is seldom possible. Multiple interventions and lifelong surveillance are sometimes necessary. We aim to review the MM literature and create a comprehensive overview, including an evidence-based management paradigm.
- 1 May 2023
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 5 (Supplement) , i35-i48
Open AccessMultiple meningiomas: Epidemiology, management, and outcomes
Meningiomas are the most common nonmalignant brain tumor in adults, with an increasing incidence of asymptomatic meningiomas diagnosed on more ubiquitous neuroimaging. A subset of meningioma patients bear 2 or more spatially separated synchronous or metachronous tumors termed “multiple meningiomas” (MM), reported to occur in only 1%–10% of patients, though recent data indicate higher incidence. MM constitute a distinct clinical entity, with unique etiologies including sporadic, familial and radiation-induced, and pose special management challenges. While the pathophysiology of MM is not established, theories include independent origin in disparate locations through unique genetic events, and the “monoclonal hypothesis” of a transformed neoplastic clone with subarachnoid seeding precipitating numerous distinct meningiomas. Patients with solitary meningiomas carry the risk of long-term neurological morbidity and mortality, as well as impaired health-related quality of life, despite being a generally benign and surgically curable tumor. For patients with MM, the situation is even less favorable. MM should be regarded as a chronic disease, and in many cases, the management goal is disease control, as cure is seldom possible. Multiple interventions and lifelong surveillance are sometimes necessary. We aim to review the MM literature and create a comprehensive overview, including an evidence-based management paradigm.
- Open Access
- 8 November 2022
- Published by Elsevier in World Neurosurgery
- Vol. 170, e351-e363
Long-Term Functional Outcome and Quality of Life After Surgical Evacuation of Spontaneous Supratentorial Intracerebral Hemorrhage: Results from a Swedish Nationwide Cohort
- 8 November 2022
- Published by Elsevier in World Neurosurgery
- Vol. 170, e351-e363
Open AccessLong-Term Functional Outcome and Quality of Life After Surgical Evacuation of Spontaneous Supratentorial Intracerebral Hemorrhage: Results from a Swedish Nationwide Cohort
- 11 February 2022
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 22 (4) , e162-e163
Microscopic Unilateral Laminotomy for Bilateral Decompression: 2-Dimensional Operative Video
- 11 February 2022
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 22 (4) , e162-e163
Microscopic Unilateral Laminotomy for Bilateral Decompression: 2-Dimensional Operative Video
- 1 September 2020
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 133 (3) , 800-807
A grading scale for surgically treated patients with spontaneous supratentorial intracerebral hemorrhage: the Surgical Swedish ICH Score
OBJECTIVE: The authors aimed to develop the first clinical grading scale for patients with surgically treated spontaneous supratentorial intracerebral hemorrhage (ICH).METHODS: A nationwide multicenter study including 401 ICH patients surgically treated by craniotomy and evacuation of a spontaneous supratentorial ICH was conducted between January 1, 2011, and December 31, 2015. All neurosurgical centers in Sweden were included. All medical records and neuroimaging studies were retrospectively reviewed. Independent predictors of 30-day mortality were identified by logistic regression. A risk stratification scale (the Surgical Swedish ICH [SwICH] Score) was developed using weighting of independent predictors based on strength of association.RESULTS: Factors independently associated with 30-day mortality were Glasgow Coma Scale (GCS) score (p = 0.00015), ICH volume ≥ 50 mL (p = 0.031), patient age ≥ 75 years (p = 0.0056), prior myocardial infarction (MI) (p = 0.00081), and type 2 diabetes (p = 0.0093). The Surgical SwICH Score was the sum of individual points assigned as follows: GCS score 15–13 (0 points), 12–5 (1 point), 4–3 (2 points); age ≥ 75 years (1 point); ICH volume ≥ 50 mL (1 point); type 2 diabetes (1 point); prior MI (1 point). Each increase in the Surgical SwICH Score was associated with a progressively increased 30-day mortality (p = 0.0002). No patient with a Surgical SwICH Score of 0 died, whereas the 30-day mortality rates for patients with Surgical SwICH Scores of 1, 2, 3, and 4 were 5%, 12%, 31%, and 58%, respectively.CONCLUSIONS: The Surgical SwICH Score is a predictor of 30-day mortality in patients treated surgically for spontaneous supratentorial ICH. External validation is needed to assess the predictive value as well as the generalizability of the Surgical SwICH Score.
- 1 September 2020
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 133 (3) , 800-807
A grading scale for surgically treated patients with spontaneous supratentorial intracerebral hemorrhage: the Surgical Swedish ICH Score
OBJECTIVE: The authors aimed to develop the first clinical grading scale for patients with surgically treated spontaneous supratentorial intracerebral hemorrhage (ICH).METHODS: A nationwide multicenter study including 401 ICH patients surgically treated by craniotomy and evacuation of a spontaneous supratentorial ICH was conducted between January 1, 2011, and December 31, 2015. All neurosurgical centers in Sweden were included. All medical records and neuroimaging studies were retrospectively reviewed. Independent predictors of 30-day mortality were identified by logistic regression. A risk stratification scale (the Surgical Swedish ICH [SwICH] Score) was developed using weighting of independent predictors based on strength of association.RESULTS: Factors independently associated with 30-day mortality were Glasgow Coma Scale (GCS) score (p = 0.00015), ICH volume ≥ 50 mL (p = 0.031), patient age ≥ 75 years (p = 0.0056), prior myocardial infarction (MI) (p = 0.00081), and type 2 diabetes (p = 0.0093). The Surgical SwICH Score was the sum of individual points assigned as follows: GCS score 15–13 (0 points), 12–5 (1 point), 4–3 (2 points); age ≥ 75 years (1 point); ICH volume ≥ 50 mL (1 point); type 2 diabetes (1 point); prior MI (1 point). Each increase in the Surgical SwICH Score was associated with a progressively increased 30-day mortality (p = 0.0002). No patient with a Surgical SwICH Score of 0 died, whereas the 30-day mortality rates for patients with Surgical SwICH Scores of 1, 2, 3, and 4 were 5%, 12%, 31%, and 58%, respectively.CONCLUSIONS: The Surgical SwICH Score is a predictor of 30-day mortality in patients treated surgically for spontaneous supratentorial ICH. External validation is needed to assess the predictive value as well as the generalizability of the Surgical SwICH Score.
- 14 June 2019
- Published by Wiley in Acta Physiologica
- Vol. 227 (3) , e13335
Muscle atrophy and regeneration associated with behavioural loss and recovery of function after sciatic nerve crush
Aim: To resolve timing and coordination of denervation atrophy and the re‐innervation recovery process to discern correlations indicative of common programs governing these processes.Methods: Female Sprague‐Dawley (SD) rats had a unilateral sciatic nerve crush. Based on longitudinal behavioural observations, the triceps surae muscle was analysed at different time points post‐lesion.Results: Crush results in a loss of muscle function and mass (−30%) followed by a recovery to almost pre‐lesion status at 30 days post‐crush (dpc). There was no loss of fibres nor any significant change in the number of nuclei per fibre but a shift in fibres expressing myosins I and II that reverted back to control levels at 30 dpc. A residual was the persistence of hybrid fibres. Early on a CHNR ‐ε to ‐γ switch and a re‐expression of embryonic MyHC showed as signs of denervation. Foxo1, Smad3, Fbxo32 and Trim63 transcripts were upregulated but not Myostatin, InhibinA and ActivinR2B. Combined this suggests that the mechanism instigating atrophy provides a selectivity of pathway(s) activated. The myogenic differentiation factors (MDFs: Myog, Myod1 and Myf6) were upregulated early on suggesting a role also in the initial atrophy. The regulation of these transcripts returned towards baseline at 30 dpc. The examined genes showed a strong baseline covariance in transcript levels which dissolved in the response to crush driven mainly by the MDFs. At 30 dpc the naïve expression pattern was re‐established.Conclusion: Peripheral nerve crush offers an excellent model to assess and interfere with muscle adaptions to denervation and re‐innervation.
- 14 June 2019
- Published by Wiley in Acta Physiologica
- Vol. 227 (3) , e13335
Muscle atrophy and regeneration associated with behavioural loss and recovery of function after sciatic nerve crush
Aim: To resolve timing and coordination of denervation atrophy and the re‐innervation recovery process to discern correlations indicative of common programs governing these processes.Methods: Female Sprague‐Dawley (SD) rats had a unilateral sciatic nerve crush. Based on longitudinal behavioural observations, the triceps surae muscle was analysed at different time points post‐lesion.Results: Crush results in a loss of muscle function and mass (−30%) followed by a recovery to almost pre‐lesion status at 30 days post‐crush (dpc). There was no loss of fibres nor any significant change in the number of nuclei per fibre but a shift in fibres expressing myosins I and II that reverted back to control levels at 30 dpc. A residual was the persistence of hybrid fibres. Early on a CHNR ‐ε to ‐γ switch and a re‐expression of embryonic MyHC showed as signs of denervation. Foxo1, Smad3, Fbxo32 and Trim63 transcripts were upregulated but not Myostatin, InhibinA and ActivinR2B. Combined this suggests that the mechanism instigating atrophy provides a selectivity of pathway(s) activated. The myogenic differentiation factors (MDFs: Myog, Myod1 and Myf6) were upregulated early on suggesting a role also in the initial atrophy. The regulation of these transcripts returned towards baseline at 30 dpc. The examined genes showed a strong baseline covariance in transcript levels which dissolved in the response to crush driven mainly by the MDFs. At 30 dpc the naïve expression pattern was re‐established.Conclusion: Peripheral nerve crush offers an excellent model to assess and interfere with muscle adaptions to denervation and re‐innervation.
- Open Access
- 15 March 2019
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 161 (5) , 955-965
Differences in neurosurgical treatment of intracerebral haemorrhage: a nation-wide observational study of 578 consecutive patients
Supratentorial intracerebral haemorrhage (ICH) carries an excessive mortality and morbidity. Although surgical ICH treatment can be life-saving, the indications for surgery in larger cohorts of ICH patients are controversial and not well defined. We hypothesised that surgical indications vary substantially among neurosurgical centres in Sweden.
- 15 March 2019
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 161 (5) , 955-965
Open AccessDifferences in neurosurgical treatment of intracerebral haemorrhage: a nation-wide observational study of 578 consecutive patients
Supratentorial intracerebral haemorrhage (ICH) carries an excessive mortality and morbidity. Although surgical ICH treatment can be life-saving, the indications for surgery in larger cohorts of ICH patients are controversial and not well defined. We hypothesised that surgical indications vary substantially among neurosurgical centres in Sweden.
- Open Access
- 26 July 2018
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 160 (9) , 1737-1747
Favorable clinical outcome following surgical evacuation of deep-seated and lobar supratentorial intracerebral hemorrhage: a retrospective single-center analysis of 123 cases
Background In spontaneous supratentorial intracerebral hemorrhage (ICH), the role of surgical treatment remains controversial, particularly in deep-seated ICHs. We hypothesized that early mortality and long-term functional outcome differ between patients with surgically treated lobar and deep-seated ICH. Method Patients who underwent craniotomy for ICH evacuation from 2009 to 2015 were retrospectively evaluated and categorized into two subgroups: lobar and deep-seated ICH. The modified Rankin Scale (mRS) was used to evaluate long-term functional outcome. Result Of the 123 patients operated for ICH, 49.6% (n = 61) had lobar and 50.4% (n = 62) deep-seated ICH. At long-term follow-up (mean 4.2 years), 25 patients (20.3%) were dead, while 51.0% of survivors had a favorable outcome (mRS score ≤ 3). Overall mortality was 13.0% at 30 days and 17.9% at 6 months post-ictus, not influenced by ICH location. Mortality was higher in patients ≥ 65 years old (p = 0.020). The deep-seated group had higher incidence and extent of intraventricular extension, younger age (52.6 ± 9.0 years vs. 58.5 ± 9.8 years; p < 0.05), more frequently pupillary abnormalities, and longer neurocritical care stay (p < 0.05). The proportion of patients with good outcome was 48.0% in deep-seated vs. 54.1% in lobar ICH (p = 0.552). In lobar ICH, independent predictors of long-term outcome were age, hemorrhage volume, preoperative level of consciousness, and pupillary reaction. In deep-seated ICHs, only high age correlated significantly with poor outcome. Conclusions At long-term follow-up, most ICH survivors had a favorable clinical outcome. Neither mortality nor long-term functional outcome differed between patients operated for lobar or deep-seated ICH. A combination of surgery and neurocritical care can result in favorable clinical outcome, regardless of ICH location.
- 26 July 2018
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 160 (9) , 1737-1747
Open AccessFavorable clinical outcome following surgical evacuation of deep-seated and lobar supratentorial intracerebral hemorrhage: a retrospective single-center analysis of 123 cases
Background In spontaneous supratentorial intracerebral hemorrhage (ICH), the role of surgical treatment remains controversial, particularly in deep-seated ICHs. We hypothesized that early mortality and long-term functional outcome differ between patients with surgically treated lobar and deep-seated ICH. Method Patients who underwent craniotomy for ICH evacuation from 2009 to 2015 were retrospectively evaluated and categorized into two subgroups: lobar and deep-seated ICH. The modified Rankin Scale (mRS) was used to evaluate long-term functional outcome. Result Of the 123 patients operated for ICH, 49.6% (n = 61) had lobar and 50.4% (n = 62) deep-seated ICH. At long-term follow-up (mean 4.2 years), 25 patients (20.3%) were dead, while 51.0% of survivors had a favorable outcome (mRS score ≤ 3). Overall mortality was 13.0% at 30 days and 17.9% at 6 months post-ictus, not influenced by ICH location. Mortality was higher in patients ≥ 65 years old (p = 0.020). The deep-seated group had higher incidence and extent of intraventricular extension, younger age (52.6 ± 9.0 years vs. 58.5 ± 9.8 years; p < 0.05), more frequently pupillary abnormalities, and longer neurocritical care stay (p < 0.05). The proportion of patients with good outcome was 48.0% in deep-seated vs. 54.1% in lobar ICH (p = 0.552). In lobar ICH, independent predictors of long-term outcome were age, hemorrhage volume, preoperative level of consciousness, and pupillary reaction. In deep-seated ICHs, only high age correlated significantly with poor outcome. Conclusions At long-term follow-up, most ICH survivors had a favorable clinical outcome. Neither mortality nor long-term functional outcome differed between patients operated for lobar or deep-seated ICH. A combination of surgery and neurocritical care can result in favorable clinical outcome, regardless of ICH location.